Latest Market News

Cogstate Ltd has upgraded its FY25 financial guidance, projecting a 20-24% revenue increase and nearly doubling profit before tax compared to last year.

Podium Minerals has successfully raised approximately A$2.6 million through an oversubscribed entitlement offer, securing strong shareholder support to advance key metallurgical work and maintain strategic tenements at its Parks Reef Project.

Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.

Brookside Energy has expanded its SWISH Play acreage in Oklahoma's Anadarko Basin by adding a fifth Drilling Spacing Unit, increasing its high-impact drilling inventory by over a quarter. This move strengthens its development pipeline ahead of a planned NYSE listing.

Lefroy Exploration has reported strong, consistent gold assay results from its Lucky Strike deposit, reinforcing confidence in its resource model as it advances towards mining operations targeted for early 2026.

Novo Resources Corp has significantly enhanced its exploration portfolio with new farm-in agreements and a joint venture with Northern Star Resources, targeting standalone gold and copper projects with over 1 million ounces potential.

Vulcan Steel has extended the relaxation of its banking covenant thresholds through June 2026, reinforcing its liquidity position amid uncertain economic conditions.

Fletcher Building unveiled a comprehensive strategic review and FY25 outlook at its Investor Day, highlighting a focus on manufacturing and distribution alongside significant restructuring costs. The company targets a leaner operation with disciplined capital management and a net debt goal of NZD 400m to 900m.

Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.

HITIQ Limited has closed its pro-rata rights issue, raising $360,426 before costs, and is now focusing on placing the remaining shortfall of shares within three months.

Engenco Limited is set for trading suspension and delisting from the ASX after Elph Investments secures a 95.57% stake and moves to compulsorily acquire remaining shares.

INOVIQ Limited has responded to ASX queries defending its announcement that its new CAR-NK-EV treatment killed 88% of breast and lung cancer cells in vitro, confirming compliance with disclosure rules and providing detailed study data.